Values First Advisors Inc. Acquires Shares of 2,072 Inspire Medical Systems, Inc. (NYSE:INSP)

Values First Advisors Inc. acquired a new stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 2,072 shares of the company's stock, valued at approximately $329,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Huntington National Bank boosted its stake in Inspire Medical Systems by 228.3% during the 4th quarter. Huntington National Bank now owns 174 shares of the company's stock valued at $32,000 after purchasing an additional 121 shares during the period. True Wealth Design LLC lifted its stake in shares of Inspire Medical Systems by 39.0% in the 4th quarter. True Wealth Design LLC now owns 196 shares of the company's stock worth $36,000 after acquiring an additional 55 shares during the period. Harbour Investments Inc. boosted its holdings in shares of Inspire Medical Systems by 101.0% in the fourth quarter. Harbour Investments Inc. now owns 197 shares of the company's stock valued at $37,000 after acquiring an additional 99 shares in the last quarter. Parallel Advisors LLC boosted its holdings in shares of Inspire Medical Systems by 356.5% in the first quarter. Parallel Advisors LLC now owns 210 shares of the company's stock valued at $33,000 after acquiring an additional 164 shares in the last quarter. Finally, AlphaQuest LLC boosted its holdings in shares of Inspire Medical Systems by 7,275.0% in the fourth quarter. AlphaQuest LLC now owns 295 shares of the company's stock valued at $55,000 after acquiring an additional 291 shares in the last quarter. 94.91% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on INSP. KeyCorp decreased their price objective on shares of Inspire Medical Systems from $234.00 to $216.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Stifel Nicolaus decreased their price objective on shares of Inspire Medical Systems from $190.00 to $175.00 and set a "hold" rating for the company in a report on Monday, April 21st. Robert W. Baird increased their price objective on shares of Inspire Medical Systems from $230.00 to $236.00 and gave the company an "outperform" rating in a report on Tuesday, May 6th. Morgan Stanley decreased their price objective on shares of Inspire Medical Systems from $220.00 to $200.00 and set an "overweight" rating for the company in a report on Tuesday, May 6th. Finally, Royal Bank Of Canada decreased their price objective on shares of Inspire Medical Systems from $260.00 to $215.00 and set an "outperform" rating for the company in a report on Tuesday, April 15th. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $211.91.

Inspire Medical Systems Trading Up 0.8%

INSP stock traded up $1.05 on Wednesday, hitting $134.50. 353,135 shares of the company's stock traded hands, compared to its average volume of 553,797. Inspire Medical Systems, Inc. has a 1-year low of $123.00 and a 1-year high of $225.00. The stock has a market cap of $3.97 billion, a price-to-earnings ratio of 61.98, a P/E/G ratio of 2.04 and a beta of 1.25. The stock has a fifty day moving average of $140.52 and a 200-day moving average of $162.57.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.33. Inspire Medical Systems had a net margin of 7.92% and a return on equity of 10.00%. The business had revenue of $201.32 million for the quarter, compared to analyst estimates of $194.89 million. During the same quarter in the previous year, the business earned ($0.34) earnings per share. The firm's revenue was up 22.7% compared to the same quarter last year. On average, equities research analysts anticipate that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Shawn Mccormick sold 360 shares of the business's stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $160.00, for a total transaction of $57,600.00. Following the sale, the director owned 24,046 shares in the company, valued at $3,847,360. The trade was a 1.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 4.10% of the stock is owned by corporate insiders.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.